Martine Bruley Rosset UMR S 938 INSERM Hôpital St Antoine Paris France

Slides:



Advertisements
Similar presentations
Distinctive characteristics
Advertisements

Introduction to Immunology BIOS 486A/586A Kenneth J. Goodrum,Ph.D. Department of Biomedical Sciences Ohio University 2005.
Lecture outline The nomenclature of Immunology Types of immunity (innate and adaptive; active and passive; humoral and cell- mediated) Features of immune.
Lecture outline The nomenclature of Immunology
T cell-mediated immunity Chapter 8
Introduction to Autoimmunity Alon Monsonego, Ph.D. The department of Microbiology and Immunology Tel:
Immunity : The Immune system plays a role in combating infection, creating inflammation (& consequently heart disease), controlling (or not) cancer and.
Reverse Vaccine in Type 1 DM
Lecture 22 Autoimmunity.
The Immune System Bryce Tappan. Function of the Immune System The purpose of the immune system is to protect an organism from external dangers such as.
Lecture 14 Immunology: Adaptive Immunity. Principles of Immunity Naturally Acquired Immunity- happens through normal events Artificially Acquired Immunity-
Phylogenetic relationship of lentiviruses. - The heterologous host all develop disease that show many parallels to human AIDS, the similarities including.
Hypothesis 1: Chimerism induces a graft-versus-host reaction Host B lymphocyte B B B B Chimeric Th lymphocyte Chimeric CTL Stimulation No elimination or.
Evgeniya Solodova Introduction: Regulatory cytokine transforming growth factor-β (TGF-β): - - is a secreted protein that exists in three isoforms.
8 Immunity: defence against disease. Immunity Infection is entry into the body of a micro-organism that may cause disease. Infection does not necessarily.
Basic Immunology The Immune system must have the ability to distinguish between self and non-self molecules Self Molecules- components of an organism’s.
Immune System SC.912.L Explain the basic functions of the human immune system, including specific and nonspecific immune response, vaccines, and.
Infectious diseases Tissue transplantation Elimination of tumors Autoimmune diseases Gatekeeper function Sensing pathogens Priming adaptive immune responses.
Germline-encoded receptors Gene rearranged receptors: TCR/BCR Ags………. Innate immunity Adaptive immunity B/T cells Pattern recognition Epitope recognition.
Proteins as Pathogens Stanley B. Prusiner, MD The Nobel Prize in Physiology or Medicine Presented by Shannon S. Rickner-Schmidt.
IMMUNOLOGICAL TOLERANCE Lecture 6 Jan Żeromski 2007/2008.
IDO Activates Regulatory T Cells and Blocks Their Conversion into Th17-Like T Cells The Journal of Immunology 주 지 민.
GENERAL IMMUNOLOGY PHT 324
+/- antigen specific T cells
INTRODUCTION TO THE IMMUNE SYSTEM
Pathogenic and Protective Roles of MyD88 in Leukocytes and Epithelial Cells in Mouse Models of Inflammatory Bowel Disease  Mark J. Asquith, Olivier Boulard,
B Cells: Regulatory (Bregs)
Flow cytometry plot gated on human CD4 T cells
Mechanisms of Autoimmunity Department of Pathology
Immunology Ch Microbiology.
The immune system and the oral cavity
Foxp3+ Regulatory T Cells Promote T Helper 17 Cell Development In Vivo through Regulation of Interleukin-2 Immunity 34, 409–421, March 25, 2011 Yi Chen,
Disease Transmission and Species Barrier
Chapter 9 T-cell Development
Vaccination -Several weeks are required before the immune system develops immunity to a new antigen -To overcome this problem, vaccinations safely give.
Immunological memory Topics Immune regulation  T cells
Immunological Tolerance
Tolerance Ray Owens in 1945 showed that dizygotic cattle twins, which shared a common vascular system in utero, were mutually tolerant of skin grafts from.
Volume 33, Issue 3, Pages (September 2010)
IL-2–Targeted Therapy Ameliorates the Severity of Graft-versus-Host Disease: Ex Vivo Selective Depletion of Host-Reactive T Cells and In Vivo Therapy 
Juyang Kim, Wongyoung Kim, Hyun J. Kim, Sohye Park, Hyun-A
Identification of CD3+CD4−CD8− T Cells as Potential Regulatory Cells in an Experimental Murine Model of Graft-Versus-Host Skin Disease (GVHD)  Fumi Miyagawa,
IMMUNITY QUICK REVIEW.
Induction and role of regulatory CD4+CD25+ T cells in tolerance to the transgene product following hepatic in vivo gene transfer by Ou Cao, Eric Dobrzynski,
Results of Phase 1 Trial of Treg Adoptive Cell Transfer in Living Donor Kidney Transplant Recipients TRACT Therapeutics™
Immunologic Tolerance
Immune Tolerance to Self-Major Histocompatability Complex Class II Antigens after Bone Marrow Transplantation: Role of Regulatory T Cells  Allan D. Hess,
Crosstalk of regulatory T cells and tolerogenic dendritic cells prevents contact allergy in subjects with low zone tolerance  Ulrike Luckey, PhD, Talkea.
Volume 33, Issue 3, Pages (September 2010)
References Kuby Immunology 7th Edition 2013 Chapter 16 Pages Pages
Immune system and Immunity
Regulatory T Cells Control Antigen-Specific Expansion of Tfh Cell Number and Humoral Immune Responses via the Coreceptor CTLA-4  James Badger Wing, Wataru.
Volume 27, Issue 3, Pages (September 2007)
Volume 48, Issue 4, Pages e6 (April 2018)
Immunology Dr. Refif S. Al-Shawk
Immunological Tolerance
Volume 34, Issue 3, Pages (March 2011)
T Cells with Low Avidity for a Tissue-Restricted Antigen Routinely Evade Central and Peripheral Tolerance and Cause Autoimmunity  Dietmar Zehn, Michael.
Unit 7: Infectious Diseases
Mechanisms of Autoimmunity Department of Pathology
Lec.10 Immune response كلية المأمون الجامعة\قسم تقنيات التحليلات المرضية مادةالمناعة-النظري/المرحلةالثالثة م.م.رشد اياد عبدالحميد.
Intravenous immunoglobulin attenuates airway inflammation through induction of forkhead box protein 3–positive regulatory T cells  Amir H. Massoud, MSc,
Volume 34, Issue 3, Pages (March 2011)
Volume 41, Issue 2, Pages (August 2014)
Volume 33, Issue 6, Pages (December 2010)
T Cell Activation and proliferation
Protective Regulatory T Cell Generation in Autoimmune Diabetes by DNA Covaccination with Islet Antigens and a Selective CTLA-4 Ligand  Yelena Glinka,
IMMUNOLOGICAL TOLERANCE AND AUTOIMMUNITY
Volume 39, Issue 5, Pages (November 2013)
Epicutaneous Immunization with Autoantigenic Peptides Induces T Suppressor Cells that Prevent Experimental Allergic Encephalomyelitis  Margaret S. Bynoe,
Presentation transcript:

Martine Bruley Rosset UMR S 938 INSERM Hôpital St Antoine Paris France Studies of immune responses to Prion Protein (PrP) during prion infection: role of regulatory T cells Martine Bruley Rosset UMR S 938 INSERM Hôpital St Antoine Paris France

Creutzfeldt Jakob Disease Sporadic Genetic Infectious: Iatrogenic, new variant CJD Triggering event can be established a posteriori when disease emerges Long period of incubation where disease is asymptomatic before clinical signs develop in the CNS Early detection is essential for presence of infectivity for transmission application of therapy

In conventional infectious diseases, infection is usually detected by: Identification of the pathogen presence of an immune response specific to the pathogen In the case of infectious CJD: Infectious agent is normal protein (PrP), which acquires a pathological conformation (PrPSc) : no antibodies can discriminate the normal form from the pathological form PMCA is a new method for the detection of the PrPSc in body fluids No evidence of specific immune response to PrPSc : no antibodies to PrP are spontaneously produced in the blood of CJD patients precluding early detection of infection

Evidences that immune responses to PrP control prion diseases 1. Antibodies to PrP control efficiently the disease when given early after infection but not late Importance of early detection 2. Implication of T cells specific for PrP: Identification of peptide 158-187 (P9) as the main CD4+ T cell epitope of murine PrP Experimental model of murine scrapie

Questions Can prion infection be detected and/or interfere with the host immune system during the asymptomatic period ? And if so, what is the contribution of innate or adaptive arms of the immune system?

T cell response specific for P9 lasts longuer in normal than in infected mice after immunization to P9 Immunisation infection or not P9 139A

Presence of infection before immunization inhibits antibody and T cell responses to PrP peptide P9 Immunization before infection Immunization infection Immunization P9 139A P9 2 wks 7 wks Infection before immunization 2 Infection Immunization 139A P9 7 wks 13 wks Antibody response to P9 T-cell response to P9

The presence of prion infection do not interfere with the response to a foreign antigen Peptide doses 1 mg/well 0,1 µg/well 0,01 µg/well T cell response to OT2 CFA OVA CFA OVA Normal mice infected mice T cell response to OT2 (dominant CD4+T-cell epitope of ovalbumin) Antibody response to OVA

In prion-infected mice, the reduced response to P9 is restored when CD4+CD25+ Tcells were eliminated CD25-depleted CD25-depleted CD4+ P=0.05 P<0.01 .

Regulatory T cells control autoreactive T cells Thymus Specific for foreign antigen Periphery: response to pathogens T Spécifique for self-antigen T High affinity apoptose periphery Medium affinity Autoreactive T cell autoimmune aggression CD4+Foxp3- CD4+ T-cell receptor Self-PrP

Regulatory T cells control autoreactive T cells Thymus Specific for self-antigen T periphery Medium affinity Regulatory T cell CD4+CD25+Foxp3+ Autoreactive T cell autoimmune aggression CD4+Foxp3- Tregs FOXP3+ CD4+ X T-cell receptor Inhibition of proliferation CD25+ Self-PrP Tregs = 10 % of peripheral CD4+ T cells

Mice expressing Green Fluorescent Protein Foxp3 from Kiffenig/Bernard Malissen Marseille-France Foxp3+GFP mice Rapid quantification and purification to study: 1. Influence of Tregs on natural development of the disease 2. Induction of Tregs specific for PrP In infected mice After vaccination

Prion infection is associated with a moderate accumulation of CD4+CD25low Foxp3+ T cells in the spleen SPLEEN LYMPH NODES BLOOD 15,4 5,58 12,7 1,86 0,74 8,5 17,3 13,8 14,1 2,41 0,82 11,4 Foxp3-GFP mouse CD25 SSC CD4 Foxp3-GFP infected mouse GFP

Elimination of CD25+ Tregs leads to a higher accumulation of pathogenic splenic PrPsc WT 139A infected mice infected mice + PC61 p<0,001 Amount of PrPSc en WB Anti-CD25 139A mAb infection Day-3 WT mice Day+3 Day70 WT 139A infected mice + PC61

Transfert of FoxP3+ Treg cells 3 days prior to infection reduces accumulation of pathogenic PrPsc WT 139A infected mice + FoxP3-GFP+ cells p<0,001 Foxp3+GFP mice WT mice Recipient mice T cell transfer infection 2.105 Foxp3+ 139A Amount of PrPSc en WB WT 139A infected mice + FoxP3-GFP+ cells

Conclusions: Our results demonstrate that 1. The immune system reacts to prion infection 2. Regulatory T cells are important actors They are able to: - control the generation of anti-PrP specific responses - reduce the accumulation of pathogenic PrPSc in the spleen during the natural course of infection

Perspectives Confirmation of the accumulation of Tregs in lymphoid organs infected with PrPSc Kinetics, phenotype and PrPSc-specificity of Tregs? Mechanism of interaction between Tregs and PrPSc: intervention of another intermediate actor: B cells, Dendritic cells

Acknowledgements UMRS 938 INSERM 580 Antoine Sacquin David A. Gross Hôpital St Antoine Hôpital Necker Paris Paris Antoine Sacquin David A. Gross PhD student Jean Davoust